NCT07099066
Generation of Cell Banks and Biomarker Isolation From Patients With Amyotrophic Lateral Sclerosis (ALS) (HCD-SLA)
Not Yet Recruiting · Not specified · Human Cell Design · registry updated 2025-08-01
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
The aim of this research is to establish different cell banks from patients with amyotrophic lateral sclerosis (ALS).
Inclusion
- Subjects over 18 years old;
- Subjects who have given their consent and signed an informed, free and express consent form;
- Subjects with diagnosed ALS;
- Subjects affiliated to or benefiting from a social security scheme.
Exclusion
- Subjects with contraindications to the collection of biological samples (blood, skin, urine).
- Subjects undergoing treatment likely to affect hemostasis (anticoagulants, platelet anti-aggregants, etc.) in the month prior to inclusion and during the study;
- Subjects with hereditary or acquired haemostasis disorders;
- Subjects who have undergone physical treatment (radiotherapy, etc.) on the area to be biopsied in the last 6 months;
- Lidocaine-intolerant subjects;
- Subjects who have reached the age of majority and are subject to a protective measure or are unable to express their consent.